Conscience is turning drug discovery into a team sport. We're building an open science network to collaborate across industry, academia, and the public sector; stewarding the AI-enabled computational drug discovery competition CACHE; and providing support to advance promising preclinical drug development targets in areas of market failure like rare disease, antimicrobial resistance, and pandemic preparedness.